🇺🇸 FDA
Pipeline program

153Sm-DOTMP

153Sm-TLX090-101

Phase 1 small_molecule active

Quick answer

153Sm-DOTMP for Bone Pain is a Phase 1 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Telix Pharmaceuticals Ltd
Indication
Bone Pain
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials